Impact of sodium-glucose cotransporter-2 inhibitors on kidney outcomes in type 2 diabetes: A tertiary center experience

BACKGROUND: Diabetic nephropathy (DN) is a complication of chronic hyperglycemia associated with diabetes mellitus (DM). Several studies have demonstrated the positive impact of sodium-glucose cotransporter-2 (SGLT2) inhibitors on kidney outcomes. The objective of the study was to evaluate the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawhari, Mohammed H., Aldahash, Raed A., Almutairi, Faisal M., Albogami, Mahdi S., Rokon, Ahmad E., Alsomali, Faisal A., Alanazi, Khaled H., Alshehri, Abdulrahman A., Almutairi, Talal H., Alharbi, Abdulrahman D., Alghamdi, Rayan M., Tawhari, Ibrahim H., Salih, Salih A. Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688587/
https://www.ncbi.nlm.nih.gov/pubmed/38044971
http://dx.doi.org/10.4103/jfcm.jfcm_111_23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688587/
https://www.ncbi.nlm.nih.gov/pubmed/38044971
http://dx.doi.org/10.4103/jfcm.jfcm_111_23

Ejemplares similares